Infectious risk stratification in multiple sclerosis patients receiving immunotherapy-Reference-Cited by-同舟云学术

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

Published:2017-11-24 Issue:12 Volume:4 Page:909-914
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Graf Jonas¹,Leussink Verena I.¹,Dehmel Thomas²,Ringelstein Marius¹,Goebels Norbert¹,Adams Ortwin³,MacKenzie Colin R.⁴,Warnke Clemens¹⁵,Feldt Torsten⁶,Lammerskitten Anna⁷,Klotz Luisa⁷,Meuth Sven⁷,Wiendl Heinz⁷,Hartung Hans-Peter¹,Aktas Orhan¹,Albrecht Philipp¹

Affiliation:

1. Department of Neurology; University Hospital; Medical Faculty Heinrich-Heine-University; Düsseldorf Germany

2. Novartis Pharma; Nürnberg Germany

3. Institute of Virology; University Hospital; Heinrich-Heine-University; Düsseldorf Germany

4. Institute of Medical Microbiology and Hospital Hygiene; University Hospital; Heinrich-Heine-University; Düsseldorf Germany

5. Department of Neurology; University Hospital of Cologne; Cologne Germany

6. Department of Gastroenterology, Hepatology and Infectious Diseases; University Hospital; Heinrich-Heine-University; Düsseldorf Germany

7. Department of Neurology; University Hospital of Münster; Münster Germany

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Reference18 articles.

1. Disease-modifying therapies and infectious risks in multiple sclerosis;Winkelmann;Nat Rev Neurol,2016

2. Detecting latent tuberculosis in compromised patients;Sauzullo;Curr Opin Infect Dis,2015

3. How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?;Fragoso;Expert Rev Neurother,2014

4. (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2011

5. Update on the treatment of tuberculosis and latent tuberculosis infection;Blumberg;JAMA,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latent tuberculosis prevalence, diagnosis and treatment in Multiple Sclerosis as a strategy for reducing infection reactivation during immunosuppressant therapy;Multiple Sclerosis and Related Disorders;2024-06

2. Ophthalmoplegia with a focal lesion in the interpeduncular fossa as the initial symptoms of multiple sclerosis: 3-year follow-up;Journal of International Medical Research;2024-01

3. Latent tuberculosis infection in Korean patients with multiple sclerosis and neuromyelitis optica spectrum disorder;Multiple Sclerosis and Related Disorders;2024-01

4. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD;Neurotherapeutics;2022-03-10

5. Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: A systematic review;Multiple Sclerosis and Related Disorders;2021-10